Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
Find more results for AMED
+0.10 (0.38%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.40 - 27.05
52 week 12.86 - 31.27
Open 26.63
Vol / Avg. 172,507.00/244,005.00
Mkt cap 898.40M
P/E 69.82
Div/yield     -
EPS 0.38
Shares 33.67M
Beta 0.98
Inst. own 95%
Jun 1, 2015
Amedisys, Inc. Annual Shareholder Meeting (Estimated) Add to calendar
May 6, 2015
Q1 2015 Amedisys Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 4, 2015
Q4 2014 Amedisys Inc Earnings Call - Webcast
Mar 4, 2015
Q4 2014 Amedisys Inc Earnings Release
Jan 14, 2015
Amedisys Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 3.10% 1.10%
Operating margin 4.93% 2.00%
EBITD margin - 4.61%
Return on average assets 5.54% 1.91%
Return on average equity 9.38% 3.38%
Employees 13,200 -
CDP Score - -


United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Amedisys, Inc. (Amedisys) is a health care at home company. The Company delivers personalized home health and hospice care to approximately 360,000 patients each year. It is focused on delivering patient-centered care, whether that is home-based recovery and rehabilitation after an operation or injury, care focused to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. The Company owns and operates approximately 367 Medicare-certified home health care centers, 92 Medicare-certified hospice care centers and one hospice inpatient unit. The Company operates in two segments: home health and hospice. Home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgical procedure. Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness.

Officers and directors

Paul B. Kusserow President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Ronald A. LaBorde Vice Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Dale E. Redman Interim Chief Financial Officer
Age: 66
Bio & Compensation  - Reuters
Jeffrey D. Jeter J.D. Chief Compliance Officer
Age: 42
Bio & Compensation  - Reuters
David R. Bucey General Counsel, Corporate Secretary
Age: 56
Bio & Compensation  - Reuters
Michael O. Fleming M.D. Chief Medical Officer
Age: 63
Bio & Compensation  - Reuters
Donald A. Washburn Non-Executive Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Nathaniel M. Zilkha Director
Age: 39
Bio & Compensation  - Reuters
Linda J. Hall Independent Director
Age: 65
Bio & Compensation  - Reuters
Jake L. Netterville Independent Director
Age: 76
Bio & Compensation  - Reuters